Skip to main content
Top
Published in: Diabetologia 2/2009

01-02-2009 | Article

Endocrine autoimmunity in families with type 1 diabetes: frequent appearance of thyroid autoimmunity during late childhood and adolescence

Authors: E. Bonifacio, A. Mayr, A. Knopff, A.-G. Ziegler

Published in: Diabetologia | Issue 2/2009

Login to get access

Abstract

Aims/hypothesis

Thyroid autoimmunity clusters with other endocrine and non-endocrine forms of autoimmunity. The aim of this study was to determine the chronological appearance of thyroid autoantibodies in relation to other forms of autoimmunity in at-risk children.

Methods

The BABYDIAB study follows children of parents with type 1 diabetes. Children born in Germany between 1989 and 2000 were recruited at birth and followed up at 9 months and at 2, 5, 8, 11, 14 and 17 years. Antibodies to thyroid peroxidase were measured in samples taken at the last study visit in 1,489 children and in all previous samples in children who tested positive. Islet antibodies and antibodies to 21-hydroxylase and transglutaminase were also measured in all children. Median follow-up was 8 years.

Results

The cumulative risk for developing antibodies to thyroid peroxidase was 20.3% (95% CI 12.3–28.3) by age 14 years. The risk was increased in girls (adjusted HR 2.0; 95% CI 1.2–3.4; p = 0.008), in children who had multiple first-degree family history of type 1 diabetes (adjusted HR 3.3; 95% CI 1.4–8.0; p = 0.006) and in children who also had antibodies to GAD (adjusted HR 3.0; 95% CI 1.5–5.9; p = 0.001). Thyroid peroxidase antibody appearance was most common from age 8 years and was often the last autoantibody to develop in children with other autoantibodies.

Conclusions/interpretation

Among children of patients with type 1 diabetes, the appearance of thyroid autoantibodies is frequent, is not synchronous to the appearance of other autoantibodies and is most common in late childhood and adolescence.
Literature
1.
go back to reference Betterle C, Dal Pra C, Mantero F, Zanchetta R (2002) Autoimmune adrenal insufficiency and autoimmune polyendocrine syndromes: autoantibodies, autoantigens, and their applicability in diagnosis and disease prediction. Endocrine Rev 23:327–364CrossRef Betterle C, Dal Pra C, Mantero F, Zanchetta R (2002) Autoimmune adrenal insufficiency and autoimmune polyendocrine syndromes: autoantibodies, autoantigens, and their applicability in diagnosis and disease prediction. Endocrine Rev 23:327–364CrossRef
2.
go back to reference Jaeger C, Hatziagelaki E, Petzoldt R, Bretzel RG (2001) Comparative analysis of organ-specific autoantibodies and celiac disease-associated antibodies in type 1 diabetic patient, their first-degree relatives, and healthy control subjects. Diabetes Care 24:27–32PubMedCrossRef Jaeger C, Hatziagelaki E, Petzoldt R, Bretzel RG (2001) Comparative analysis of organ-specific autoantibodies and celiac disease-associated antibodies in type 1 diabetic patient, their first-degree relatives, and healthy control subjects. Diabetes Care 24:27–32PubMedCrossRef
3.
go back to reference Hummel M, Bonifacio E, Stern M, Dittler J, Schimmel A, Ziegler AG (2000) Development of celiac disease-associated antibodies in offspring of parents with Type 1 diabetes. Diabetologia 43:1005–1011PubMedCrossRef Hummel M, Bonifacio E, Stern M, Dittler J, Schimmel A, Ziegler AG (2000) Development of celiac disease-associated antibodies in offspring of parents with Type 1 diabetes. Diabetologia 43:1005–1011PubMedCrossRef
4.
go back to reference Kordonouri O, Klinghammer A, Lang EB, Grüters-Kieslich A, Grabert M, Holl RW (2002) Thyroid autoimmunity in children and adolescents with type 1 diabetes. Diabetes Care 25:1346–1350PubMedCrossRef Kordonouri O, Klinghammer A, Lang EB, Grüters-Kieslich A, Grabert M, Holl RW (2002) Thyroid autoimmunity in children and adolescents with type 1 diabetes. Diabetes Care 25:1346–1350PubMedCrossRef
5.
go back to reference Barker JM, Yu J, Yu L et al (2005) Autoantibody “subspecificity” in type 1 diabetes. Diabetes Care 28:850–855PubMedCrossRef Barker JM, Yu J, Yu L et al (2005) Autoantibody “subspecificity” in type 1 diabetes. Diabetes Care 28:850–855PubMedCrossRef
6.
go back to reference Hanukoglu A, Mizrachi A, Dalal I et al (2003) Extrapancreatic autoimmune manifestations in type 1 diabetes patients and their first-degree relatives. Diabetes Care 26:1235–1240PubMedCrossRef Hanukoglu A, Mizrachi A, Dalal I et al (2003) Extrapancreatic autoimmune manifestations in type 1 diabetes patients and their first-degree relatives. Diabetes Care 26:1235–1240PubMedCrossRef
7.
go back to reference Betterle C, Zanette F, Pedini B et al (1984) Clinical and subclinical organ-specific autoimmune manifestations in Type 1 (insulin-dependent) diabetic patients and their first-degree relatives. Diabetologia 26:431–436PubMedCrossRef Betterle C, Zanette F, Pedini B et al (1984) Clinical and subclinical organ-specific autoimmune manifestations in Type 1 (insulin-dependent) diabetic patients and their first-degree relatives. Diabetologia 26:431–436PubMedCrossRef
8.
go back to reference Hummel S, Hummel M, Banholzer J et al (2007) Development of autoimmunity to transglutaminase C in children of patients with type 1 diabetes: relationship to islet autoantibodies and infant feeding. Diabetologia 50:390–394PubMedCrossRef Hummel S, Hummel M, Banholzer J et al (2007) Development of autoimmunity to transglutaminase C in children of patients with type 1 diabetes: relationship to islet autoantibodies and infant feeding. Diabetologia 50:390–394PubMedCrossRef
9.
go back to reference Liu E, Eisenbarth GS (2007) Accepting clocks that tell time poorly: fluid-phase versus standard ELISA autoantibody assays. Clin Immunol 125:120–126PubMedCrossRef Liu E, Eisenbarth GS (2007) Accepting clocks that tell time poorly: fluid-phase versus standard ELISA autoantibody assays. Clin Immunol 125:120–126PubMedCrossRef
10.
go back to reference Scofield RH (2004) Autoantibodies as predictors of disease. Lancet 386:1544–1546CrossRef Scofield RH (2004) Autoantibodies as predictors of disease. Lancet 386:1544–1546CrossRef
11.
go back to reference Ziegler AG, Hummel M, Schenker M, Bonifacio E (1999) Autoantibody appearance and risk for development of childhood diabetes in offspring of parents with type 1 diabetes: the 2-year analysis of the German BABYDIAB Study. Diabetes 48:460–468PubMedCrossRef Ziegler AG, Hummel M, Schenker M, Bonifacio E (1999) Autoantibody appearance and risk for development of childhood diabetes in offspring of parents with type 1 diabetes: the 2-year analysis of the German BABYDIAB Study. Diabetes 48:460–468PubMedCrossRef
12.
go back to reference Achenbach P, Bonifacio E, Koczwara K, Ziegler AG (2005) Natural history of type 1 diabetes. Diabetes 54(Suppl. 2):S25–S31PubMedCrossRef Achenbach P, Bonifacio E, Koczwara K, Ziegler AG (2005) Natural history of type 1 diabetes. Diabetes 54(Suppl. 2):S25–S31PubMedCrossRef
13.
go back to reference Walter M, Albert E, Conrad M et al (2003) IDDM2/insulin VNTR modifies risk conferred by IDDM1/HLA for development of Type 1 diabetes and associated autoimmunity. Diabetologia 46:712–720PubMedCrossRef Walter M, Albert E, Conrad M et al (2003) IDDM2/insulin VNTR modifies risk conferred by IDDM1/HLA for development of Type 1 diabetes and associated autoimmunity. Diabetologia 46:712–720PubMedCrossRef
14.
go back to reference Barker JM, Barriga KJ, Yu L et al (2004) Diabetes Autoimmunity Study in the Young. Prediction of autoantibody positivity and progression to type 1 diabetes: Diabetes Autoimmunity Study in the Young (DAISY). J Clin Endocrinol Metab 89:3896–3902PubMedCrossRef Barker JM, Barriga KJ, Yu L et al (2004) Diabetes Autoimmunity Study in the Young. Prediction of autoantibody positivity and progression to type 1 diabetes: Diabetes Autoimmunity Study in the Young (DAISY). J Clin Endocrinol Metab 89:3896–3902PubMedCrossRef
15.
go back to reference Knip M, Kukko M, Kulmala P et al (2002) Humoral beta-cell autoimmunity in relation to HLA-defined disease susceptibility in preclinical and clinical type 1 diabetes. Am J Med Genet 115:48–54PubMedCrossRef Knip M, Kukko M, Kulmala P et al (2002) Humoral beta-cell autoimmunity in relation to HLA-defined disease susceptibility in preclinical and clinical type 1 diabetes. Am J Med Genet 115:48–54PubMedCrossRef
16.
go back to reference Ziegler AG, Schmid S, Huber D, Hummel M, Bonifacio E (2003) Early infant feeding and risk of developing type 1 diabetes-associated autoantibodies. JAMA 290:1721–1728PubMedCrossRef Ziegler AG, Schmid S, Huber D, Hummel M, Bonifacio E (2003) Early infant feeding and risk of developing type 1 diabetes-associated autoantibodies. JAMA 290:1721–1728PubMedCrossRef
17.
go back to reference Norris JM, Barriga K, Klingensmith G et al (2003) Timing of cereal exposure in infancy affects risk of islet autoimmunity. The Diabetes Autoimmunity Study in the Young. JAMA 290:1713–1720PubMedCrossRef Norris JM, Barriga K, Klingensmith G et al (2003) Timing of cereal exposure in infancy affects risk of islet autoimmunity. The Diabetes Autoimmunity Study in the Young. JAMA 290:1713–1720PubMedCrossRef
18.
go back to reference Norris JM, Barriga K, Hoffenberg EJ et al (2005) Risk of celiac disease autoimmunity and timing of gluten introduction in the diet of infants at increased risk of disease. JAMA 293:2343–2351PubMedCrossRef Norris JM, Barriga K, Hoffenberg EJ et al (2005) Risk of celiac disease autoimmunity and timing of gluten introduction in the diet of infants at increased risk of disease. JAMA 293:2343–2351PubMedCrossRef
19.
go back to reference Czarnocka B, Ruf J, Ferrand M, Carayon P, Lissitzky S (1985) Purification of the human thyroid peroxidase and its identification as the microsomal antigen involved in autoimmune thyroid diseases. FEBS Lett 190:147–152PubMedCrossRef Czarnocka B, Ruf J, Ferrand M, Carayon P, Lissitzky S (1985) Purification of the human thyroid peroxidase and its identification as the microsomal antigen involved in autoimmune thyroid diseases. FEBS Lett 190:147–152PubMedCrossRef
20.
go back to reference Naserke HE, Bonifacio E, Ziegler AG (1999) Immunoglobulin G insulin autoantibodies in BABYDIAB offspring appear postnatally: sensitive early detection using a protein A/G-based radiobinding assay. J Clin Endocrinol Metab 84:1239–1243PubMedCrossRef Naserke HE, Bonifacio E, Ziegler AG (1999) Immunoglobulin G insulin autoantibodies in BABYDIAB offspring appear postnatally: sensitive early detection using a protein A/G-based radiobinding assay. J Clin Endocrinol Metab 84:1239–1243PubMedCrossRef
21.
go back to reference Torn C, Mueller PW, Schlosser M, Bonifacio E, Bingley PJ, and participating laboratories (2008) Diabetes Antibody Standardization Program: evaluation of assays for autoantibodies to glutamic acid decarboxylase and islet antigen-2. Diabetologia 51:846–852PubMedCrossRef Torn C, Mueller PW, Schlosser M, Bonifacio E, Bingley PJ, and participating laboratories (2008) Diabetes Antibody Standardization Program: evaluation of assays for autoantibodies to glutamic acid decarboxylase and islet antigen-2. Diabetologia 51:846–852PubMedCrossRef
22.
go back to reference Lam-Tse WK, Batstra MR, Koeleman BP et al (2003) The association between autoimmune thyroiditis, autoimmune gastritis and type 1 diabetes. Pediatr Endocrinol Rev 1:22–37PubMed Lam-Tse WK, Batstra MR, Koeleman BP et al (2003) The association between autoimmune thyroiditis, autoimmune gastritis and type 1 diabetes. Pediatr Endocrinol Rev 1:22–37PubMed
23.
go back to reference Riley WJ, Maclaren WJ, Lezotte DC, Spillar RP, Rosenbloom AL (1981) Thyroid autoimmunity in insulin-dependent diabetes mellitus: the case for routine screening. J Pediatr 99:350–354PubMedCrossRef Riley WJ, Maclaren WJ, Lezotte DC, Spillar RP, Rosenbloom AL (1981) Thyroid autoimmunity in insulin-dependent diabetes mellitus: the case for routine screening. J Pediatr 99:350–354PubMedCrossRef
24.
go back to reference McKenna MJ, Hershkowitz R, Wolfsdorf JI (1990) Screening for thyroid disease in children with IDDM. Diabetes Care 13:801–803PubMedCrossRef McKenna MJ, Hershkowitz R, Wolfsdorf JI (1990) Screening for thyroid disease in children with IDDM. Diabetes Care 13:801–803PubMedCrossRef
25.
go back to reference Burek CL, Rose NR, Guire KE, Hoffman WH (1990) Thyroid autoantibodies in black and white children and adolescents with type 1 diabetes mellitus and their first degree relatives. Autoimmunity 7:157–167PubMedCrossRef Burek CL, Rose NR, Guire KE, Hoffman WH (1990) Thyroid autoantibodies in black and white children and adolescents with type 1 diabetes mellitus and their first degree relatives. Autoimmunity 7:157–167PubMedCrossRef
26.
go back to reference Lorini R, d’Annunzio G, Vitali L, Scaramuzza A (1996) IDDM and autoimmune thyroid disease in the pediatric age group. J Pediatr Endocrinol Metab 9(Suppl. 1):89–94PubMed Lorini R, d’Annunzio G, Vitali L, Scaramuzza A (1996) IDDM and autoimmune thyroid disease in the pediatric age group. J Pediatr Endocrinol Metab 9(Suppl. 1):89–94PubMed
27.
go back to reference Maugendre D, Massart C, Karacatsanis C et al (1997) Increased prevalence of thyroid autoantibodies and subclinical thyroid failure in relatives of patients with overt endocrine disease-associated diabetes but not type 1 diabetes alone. Diabetes Metab 23:302–307PubMed Maugendre D, Massart C, Karacatsanis C et al (1997) Increased prevalence of thyroid autoantibodies and subclinical thyroid failure in relatives of patients with overt endocrine disease-associated diabetes but not type 1 diabetes alone. Diabetes Metab 23:302–307PubMed
28.
go back to reference Lindberg B, Ericsson UB, Ljung R, Ivarsson SA (1997) High prevalence of thyroid autoantibodies at diagnosis of insulin-dependent diabetes mellitus in Swedish children. J Lab Clin Med 130:585–589PubMedCrossRef Lindberg B, Ericsson UB, Ljung R, Ivarsson SA (1997) High prevalence of thyroid autoantibodies at diagnosis of insulin-dependent diabetes mellitus in Swedish children. J Lab Clin Med 130:585–589PubMedCrossRef
29.
go back to reference Chang CC, Huang CN, Chuang LM (1998) Autoantibodies to thyroid peroxidase in patients with type 1 diabetes in Taiwan. Eur J Endocrinol 139:44–48PubMedCrossRef Chang CC, Huang CN, Chuang LM (1998) Autoantibodies to thyroid peroxidase in patients with type 1 diabetes in Taiwan. Eur J Endocrinol 139:44–48PubMedCrossRef
30.
go back to reference McCanlies E, O’Leary LA, Foley TP et al (1998) Hashimoto thyroiditis and insulin- dependent diabetes mellitus: differences among individuals with and without abnormal thyroid function. J Clin Endocrinol Metab 83:1548–1551PubMedCrossRef McCanlies E, O’Leary LA, Foley TP et al (1998) Hashimoto thyroiditis and insulin- dependent diabetes mellitus: differences among individuals with and without abnormal thyroid function. J Clin Endocrinol Metab 83:1548–1551PubMedCrossRef
31.
go back to reference Roldan MB, Alonso M, Barrio R (1999) Thyroid autoimmunity in children and adolescents with type 1 diabetes mellitus. Diabetes Nutr Metab 12:27–31PubMed Roldan MB, Alonso M, Barrio R (1999) Thyroid autoimmunity in children and adolescents with type 1 diabetes mellitus. Diabetes Nutr Metab 12:27–31PubMed
32.
go back to reference Peterson P, Salmi H, Hyöty H et al (1997) Steroid 21-hydroxylase autoantibodies in insulin-dependent diabetes mellitus. Childhood Diabetes in Finland (DiMe) Study Group. Clin Immunol Immunopathol 82:37–42PubMedCrossRef Peterson P, Salmi H, Hyöty H et al (1997) Steroid 21-hydroxylase autoantibodies in insulin-dependent diabetes mellitus. Childhood Diabetes in Finland (DiMe) Study Group. Clin Immunol Immunopathol 82:37–42PubMedCrossRef
33.
go back to reference Hummel M, Bonifacio E, Schmid S, Walter M, Knopff A, Ziegler AG (2003) Brief communication: early appearance of islet autoantibodies predicts childhood type 1 diabetes in offspring of diabetic parents. Ann Intern Med 140:882–886 Hummel M, Bonifacio E, Schmid S, Walter M, Knopff A, Ziegler AG (2003) Brief communication: early appearance of islet autoantibodies predicts childhood type 1 diabetes in offspring of diabetic parents. Ann Intern Med 140:882–886
34.
go back to reference Christie MR, Genovese S, Cassidy D et al (1994) Antibodies to islet 37k antigen, but not to glutamate decarboxylase, discriminate rapid progression to IDDM in endocrine autoimmunity. Diabetes 43:1254–1259PubMedCrossRef Christie MR, Genovese S, Cassidy D et al (1994) Antibodies to islet 37k antigen, but not to glutamate decarboxylase, discriminate rapid progression to IDDM in endocrine autoimmunity. Diabetes 43:1254–1259PubMedCrossRef
35.
go back to reference Levin L, Tomer Y (2003) The etiology of autoimmune diabetes and thyroiditis: evidence for common genetic susceptibility. Autoimmun Rev 2:377–386PubMedCrossRef Levin L, Tomer Y (2003) The etiology of autoimmune diabetes and thyroiditis: evidence for common genetic susceptibility. Autoimmun Rev 2:377–386PubMedCrossRef
36.
go back to reference Ide A, Eisenbarth GS (2003) Genetic susceptibility in type 1 diabetes and its associated autoimmune disorders. Rev Endocr Metab Disord 4:243–253PubMedCrossRef Ide A, Eisenbarth GS (2003) Genetic susceptibility in type 1 diabetes and its associated autoimmune disorders. Rev Endocr Metab Disord 4:243–253PubMedCrossRef
Metadata
Title
Endocrine autoimmunity in families with type 1 diabetes: frequent appearance of thyroid autoimmunity during late childhood and adolescence
Authors
E. Bonifacio
A. Mayr
A. Knopff
A.-G. Ziegler
Publication date
01-02-2009
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 2/2009
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-008-1206-6

Other articles of this Issue 2/2009

Diabetologia 2/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.